An international comparison of the reliability and responsiveness of the Duke health profile for measuring health-related quality of life of patients treated With alprostadil for erectile dysfunction

Medical Care

Volumn 37, Issue 1, 1999, Pages 56-67

  Parkerson Jr , George R ^a   Willke, Richard J ^b   Hays, Ron D ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Erectile dysfunction; Functional health status; Health outcomes; Health related quality of life; Reliability; Responsiveness

Indexed keywords

PROSTAGLANDIN E1; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; EUROPE; FOLLOW UP; HEALTH STATUS; HUMAN; IMPOTENCE; LANGUAGE; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SICKNESS IMPACT PROFILE; SOUTH AFRICA; STANDARD; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; ALPROSTADIL; EUROPE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE; SOUTH AFRICA; TRANSLATING; TREATMENT OUTCOME; UNITED STATES; VASODILATOR AGENTS;

EID: 0032609423     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199901000-00009     Document Type: Article

References (41)

1. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297.
2. Cronbach LJ, Furby L. How we should measure "change" - or should we? Psychol Bull 1970;74:68.
3. Wright BD. Solving measurement problems with the Rasch model. J Educ Meas 1977;14:97.
4. Meenan RF, Anderson JJ, Kazis LE, et al. Outcome assessment in clinical trials. Arthritis Rheum 1984;27:1344.
5. Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chron Dis 1985;38:27.
6. Deyo RA, Centor RM. Assessing the responsiveness of functional scales to clinical change: An analogy to diagnostic test performance. J Chronic Dis 1986;39:897.
7. Guyatt GH, Walter S, Norman G. Measuring change over time: Assessing the usefulness of evaluative instruments. J Chronic Dis 1987;40:171.
8. Kazis LE, Andersen JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27:178.
9. Norman GR. Issues in the use of change scores in randomized trials. J Clin Epidemiol 1989;42:1097.
10. Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990;28:632.
11. Bravo G, Potvin L. Estimating the reliability of continuous measures with Cronbach's alpha or the intraclass correlation coefficient: Toward the integration of two traditions. J Clin Epidemiol 1991;44:381.
12. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: Statistics and strategies for evaluation. Cont Clin Trials 1991;12:142S.
13. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992;30:917.
14. Silverstein B, Fisher WP, Kilgore KM, Harley JP, Harvey RF. Applying psychometric criteria to functional assessment in medical rehabilitation: II. Defining interval measures. Arch Phys Med Rehabil 1992;73:507.
15. Cortina JM. What is coefficient alpha? An examination of theory and applications. J Appl Psychol 1993;78:98.
16. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622.
17. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:81.
18. Baker DW, Hays RD, Brook RH. Understanding changes in health status. Med Care 1996;35:1.
19. Jacobs HM, Touw-Otten FWMM, de Melker RA. The evaluation of changes in functional health status in patients with abdominal complaints. J Clin Epidemiol 1996;163.
20. Krumholz HM, McHorney CA, Clark L, Levesque M, Baim DS, Goldman L. Changes in health after elective percutaneous coronary revascularization, A comparison of generic and specific measures. Med Care 1996;34:754.
21. Stucki G, Daltroy L, Katz JN, Johannesson M, Liang MH. Interpretation of change scores in ordinal clinical scales and health status measures: The whole may not equal the sum of the parts. J Clin Epidemiol 1996;49:711.
22. Ward MM. Assessing the relative sensitivity to change of rheumatoid arthritis activity measures: Is the type of treatment an important third variable? J Clin Epidemiol 1996;49:1161.
23. Wright JG, Young NL. A comparison of different indices of responsiveness. J Clin Epidemiol 1997;50:239.
24. Beaton DE, Hogg-Johnson S, Bombardier C. Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol 1997;50:79.
25. Hays RD, Anderson RT, Revicki D. Assessing reliability and validity of measurement in clinical trials. In: Staquet M, Hays RD, Fayers P, eds. Quality of life assessment in clinical trials: Methods and practice. Oxford: Oxford University Press, 1998:169.
26. Parkerson GR Jr, Broadhead WE, Tse C-KJ. The Duke Health Profile, a 17-item measure of health and dysfunction. Med Care 1990;28:1056.
27. Parkerson GR Jr, Broadhead WE, Tse C-KJ. Development of the 17-item Duke Health Profile. Fam Pract 1991;8:396.
28. Parkerson GR Jr. User's Guide for Four Duke Health Measures: Duke Health Profile (DUKE), Duke Severity of Illness Checklist (DUSOI), Duke Case-Mix System (DUMIX), Duke Social Support and Stress Scale (DUSOCS). Durham, NC: Department of Community and Family Medicine, Duke University Medical Center, 1998.
29. Linet OI, Ogrinc FG, for the alprostadil study group. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med 1996;334:873.
30. Willke RJ, Glick HA, McCarron TJ, Erder MH, Althof SE, Linet OI. Quality of life effects of alprostadil therapy for erectile dysfunction. J Urology 1997;157:2124.
31. Willke RJ, Yen WM, Parkerson GR Jr, Linet OI, Erder MH, Glick HA. Quality of life effects of alprostadil therapy for erectile dysfunction: Results of a trial in Europe and Southern Africa. Intl J Impotence Res 1998 (in press).
32. Derogatis LR, Melisaratos, N. The Brief Symptom Inventory: An introductory report. Psychol Med 1983;14:595.
33. Feldt LS, Woodruff DJ, Salih FA. Statistical inference for coefficient alpha. Applied Psychol Measurement 1987;11:93.
34. Tuley MR, Mulrow CD, McMahan CA. Estimating and testing an index of responsiveness and the relationship of the index to power. J Clin Epidemiol 1991;44:417.
35. Ware JE Jr. SF-36 Health Survey. Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
36. Nunnally JC. Psychometric Theory, 2nd edition. New York, NY: McGraw-Hill, 1978.
37. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417.
38. Derogatis LR, Meyer JK. A psychological profile of the sexual dysfunctions. Arch Sex Behav 1979;8: 201.
39. Althof SE, Turner LA, Levine SB, Risen C, Kursh ED, Bodner D, Resnick M. Intracavernosal injection in the treatment of impotence: A prospective study of sexual, psychological, and marital functioning. J Sex Marital Ther 1987;13:155.
40. Jonler M, Moon T, Brannan W, Stone NN, Henry D, Bruskewitz RC. The effect of age, ethnicity, and geographical location on impotence and quality of life. Brit J Urol 1995;75:651.
41. Hürny C, Bernard J, Coates A, et al. Responsiveness of a single-item indicator versus a multi-item scale. Med Care 1996;34:234.